Results 121 to 130 of about 1,881,625 (304)

Systematic Literature Review of Topic Labeling

open access: yesIEEE Access
The rapid growth of textual data on the web has led researchers to develop methods in Natural Language Processing (NLP) to process, understand, and identify topics.
Salma Mekaoui   +3 more
doaj   +1 more source

Towards automatic topical classification of LOD datasets

open access: yes, 2015
The datasets that are part of the Linking Open Data cloud diagramm (LOD cloud) are classified into the following topical categories: media, government, publications, life sciences, geographic, social networking, user-generated content, and cross-domain. The topical categories were manually assigned to the datasets.
Meusel, Robert   +3 more
openaire   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Defining 'democracy': Are we staying on topic? [PDF]

open access: yes
Political scientists' failure to pay careful attention to the content (as opposed to the operationalization) of their chosen definition of 'democracy' can make them liable to draw invalid inferences from their empirical research.
Ingham, Sean, Wiens, David
core  

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

open access: yesMolecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez   +17 more
wiley   +1 more source

Topic Modeling: A Consistent Framework for Comparative Studies

open access: yesEmerging Science Journal
In recent years, the field of Topic Modeling (TM) has grown in importance due to the increasing availability of digital text data. TM is an unsupervised learning technique that helps uncover latent semantic structures in large sets of documents, making ...
Ana Amaro, Fernando Bacao
doaj   +1 more source

SIB-200: A Simple, Inclusive, and Big Evaluation Dataset for Topic Classification in 200+ Languages and Dialects

open access: green, 2023
David Ifeoluwa Adelani   +7 more
openalex   +2 more sources

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

open access: yesMolecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen   +12 more
wiley   +1 more source

Topic Segmentation of Semi-Structured and Unstructured Conversational Datasets using Language Models

open access: green, 2023
Reshmi Ghosh   +6 more
openalex   +2 more sources

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

open access: yesMolecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy